GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grand Pharmaceutical Group Ltd (FRA:MX6A) » Definitions » 5-Year ROIIC %

Grand Pharmaceutical Group (FRA:MX6A) 5-Year ROIIC % : 26.03% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Grand Pharmaceutical Group 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Grand Pharmaceutical Group's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was 26.03%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Grand Pharmaceutical Group's 5-Year ROIIC % or its related term are showing as below:

FRA:MX6A's 5-Year ROIIC % is ranked better than
79.79% of 950 companies
in the Drug Manufacturers industry
Industry Median: 3.5 vs FRA:MX6A: 26.03

Grand Pharmaceutical Group 5-Year ROIIC % Historical Data

The historical data trend for Grand Pharmaceutical Group's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Pharmaceutical Group 5-Year ROIIC % Chart

Grand Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.40 15.45 11.78 13.64 26.03

Grand Pharmaceutical Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13.64 - 26.03 -

Competitive Comparison of Grand Pharmaceutical Group's 5-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grand Pharmaceutical Group's 5-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Grand Pharmaceutical Group's 5-Year ROIIC % falls into.



Grand Pharmaceutical Group 5-Year ROIIC % Calculation

Grand Pharmaceutical Group's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( 268.0517086 (Dec. 2023) - 88.910772 (Dec. 2018) )/( 2277.792 (Dec. 2023) - 1536.469 (Dec. 2018) )
=179.1409366/741.323
=24.17%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Grand Pharmaceutical Group  (FRA:MX6A) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Grand Pharmaceutical Group 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Grand Pharmaceutical Group's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG
Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from the PRC and also has a presence in America; Europe; Asia other than the PRC and others.

Grand Pharmaceutical Group Headlines

No Headlines